Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study (Q42252824)

19 October 2017

title

Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study (English)

1 reference

19 October 2017

1 reference

Peng Ruan

1

1 reference

19 October 2017

Shao-Yong Xu

2

1 reference

19 October 2017

Bo-Ping Zhou

3

1 reference

19 October 2017

Jian Huang

4

1 reference

19 October 2017

Zuo-Jiong Gong

5

1 reference

19 October 2017

publication date

1 August 2013

1 reference

Journal of International Medical Research

19 October 2017

published in

1 reference

19 October 2017

volume

41

1 reference

19 October 2017

issue

5

1 reference

19 October 2017

page(s)

1732-1739

1 reference

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Control of cccDNA function in hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Methylation regulates hepatitis B viral protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Immunopathogenesis of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Dynamics of HBV cccDNA expression and transcription in different cell growth phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Pretreatment serum HBsAg-to-HBV DNA ratio predicts a virologic response to entecavir in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060513487643

21 January 2018

Identifiers

DOI

10.1177/0300060513487643

1 reference

19 October 2017

1 reference